Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amgen
Pharma
FDA approves Amgen's potential lung cancer blockbuster Imdelltra
The FDA has signed off on Amgen's potential blockbuster Imdelltra to treat patients with extensive-stage small-cell lung cancer.
Kevin Dunleavy
May 17, 2024 12:12pm
Another quarter of growth in pharma with Lilly rising to the top
May 16, 2024 1:30pm
New name takes top spot in US patient group reputation ranking
May 14, 2024 10:54am
Amid buzz for Amgen's obesity drug, company sees revenue boost
May 3, 2024 9:05am
Amgen CEO nabs pay raise thanks to Horizon deal
Apr 18, 2024 5:08pm
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am